Jupiter Topco LLC Purchases Shares of 23,283 Cabot Corporation $CBT

Jupiter Topco LLC purchased a new position in Cabot Corporation (NYSE:CBT) in the second quarter, HoldingsChannel.com reports. The firm purchased 23,283 shares of the specialty chemicals company’s stock, valued at approximately $2,116,000.

A number of other large investors have also recently made changes to their positions in the stock. Rothschild Investment LLC increased its holdings in Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 259 shares in the last quarter. Northwestern Mutual Wealth Management Co. bought a new stake in Cabot during the 2nd quarter worth approximately $33,000. Global Retirement Partners LLC lifted its holdings in Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 466 shares in the last quarter. Geneos Wealth Management Inc. boosted its position in shares of Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Finally, Danske Bank A S bought a new position in shares of Cabot in the third quarter worth approximately $38,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Stock Performance

CBT opened at $81.26 on Friday. The stock has a market capitalization of $4.19 billion, a price-to-earnings ratio of 22.89, a PEG ratio of 10.88 and a beta of 0.83. The company has a fifty day moving average of $86.91 and a 200 day moving average of $81.40. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping the consensus estimate of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. During the same quarter in the previous year, the company earned $1.90 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, sell-side analysts forecast that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be given a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s payout ratio is currently 53.24%.

Analyst Ratings Changes

Several brokerages have recently commented on CBT. UBS Group decreased their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 5th. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. JPMorgan Chase & Co. raised their price target on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Truist Financial set a $100.00 price objective on Cabot in a research note on Wednesday, August 5th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $89.00.

Insider Buying and Selling

In related news, CEO Sean Keohane sold 134,895 shares of the stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at approximately $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders sold 229,597 shares of company stock worth $19,646,746 over the last three months. 3.08% of the stock is currently owned by corporate insiders.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.